Health
J&J starts human study of COVID-19 vaccine after promising monkey data – Yahoo Finance
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published…
By Julie Steenhuysen
(Reuters) – Johnson & Johnson <JNJ.N> on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in na…
-
Noosa News15 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News17 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General21 hours agoOne person dead after house fire in Melbourne’s south-east
-
General14 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win